Across all semaglutide treatment arms, the most frequent AEs were gastrointestinal disorders (most commonly nausea, diarrhoea and vomiting), the majority of which were mild/moderate in severity
Furthermore, additional studies provided evidence that the drug itself caused problems by slowing or halting the stomach muscles, leading to blockages within the gastrointestinal tract
Neuropsychiatric profiles in mild cognitive impairment with Lewy bodies
Other growth factors such as bone morphogenetic proteins (BMPs) have received FDA approval for specific indications and may represent more appropriate therapeutic choices for conditions where approved therapies are available and indicated
Includes 3 boxes, 90 capsules total, with Arginine, Tribulus, Garcinia and herbal extracts